{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:29:48Z","timestamp":1790126988097,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","worldneurosurgery.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.wneu.2016.10.015","type":"journal-article","created":{"date-parts":[[2016,10,16]],"date-time":"2016-10-16T01:14:05Z","timestamp":1476580445000},"page":"279-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Tumor Location and Survival Outcomes in Adult Patients with Supratentorial Glioblastoma by Levels of Toll-Like Receptor 9 Expression"],"prefix":"10.1016","volume":"97","author":[{"given":"Linsen","family":"Mu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewei","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuzhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2016.10.015_bib1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1017\/S0317167100012166","article-title":"Glioblastoma: patterns of recurrence and efficacy of salvage treatments","volume":"38","author":"Oh","year":"2011","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.wneu.2016.10.015_bib2","doi-asserted-by":"crossref","first-page":"18403","DOI":"10.18632\/oncotarget.7580","article-title":"Systematic characterization of lncRNAs' cell-to-cell expression heterogeneity in glioblastoma cells","volume":"7","author":"Lv","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.wneu.2016.10.015_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.15252\/emmm.201505495","article-title":"Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic","volume":"8","author":"Teplyuk","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.wneu.2016.10.015_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12935-016-0306-5","article-title":"The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines","volume":"16","author":"de Andrade","year":"2016","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.wneu.2016.10.015_bib5","first-page":"720","article-title":"VEGF manipulation in glioblastoma","volume":"29","author":"Weathers","year":"2015","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.wneu.2016.10.015_bib6","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2016.10.015_bib7","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1200\/JCO.2013.49.6968","article-title":"Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial","volume":"31","author":"Gilbert","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2016.10.015_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1042\/CS20110164","article-title":"Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential","volume":"121","author":"Hanke","year":"2011","journal-title":"Clin Sci"},{"key":"10.1016\/j.wneu.2016.10.015_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11060-008-9536-2","article-title":"Expression of TLR9 within human glioblastoma","volume":"88","author":"Meng","year":"2008","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2016.10.015_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.coph.2007.09.009","article-title":"Toll-like receptors: novel pharmacological targets for the treatment of neurological diseases","volume":"8","author":"Marsh","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.wneu.2016.10.015_bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1186\/1471-2407-10-415","article-title":"TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients","volume":"10","author":"Wang","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.wneu.2016.10.015_bib12","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.3892\/mmr.2014.2549","article-title":"Clinical characteristics and pathogenesis of cerebellar glioblastoma","volume":"10","author":"Takahashi","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.wneu.2016.10.015_bib13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neuchi.2014.02.008","article-title":"Early presentation of primary glioblastoma","volume":"60","author":"Faguer","year":"2014","journal-title":"Neurochirurgie"},{"key":"10.1016\/j.wneu.2016.10.015_bib14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.5414\/NP300439","article-title":"Primary human glioblastomas -prognostic value of clinical and histopathological parameters","volume":"31","author":"Habberstad","year":"2012","journal-title":"Clin Neuropathol"},{"key":"10.1016\/j.wneu.2016.10.015_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jocn.2011.03.037","article-title":"TLR9 expression is associated with prognosis in patients with glioblastoma multiforme","volume":"19","author":"Leng","year":"2012","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2016.10.015_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2015.11.029","article-title":"CpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma model","volume":"373","author":"Jordan","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.wneu.2016.10.015_bib17","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s13277-012-0416-1","article-title":"CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-\u03baB activation and NO production","volume":"33","author":"Li","year":"2012","journal-title":"Tumour Biol"},{"key":"10.1016\/j.wneu.2016.10.015_bib18","doi-asserted-by":"crossref","first-page":"6720","DOI":"10.4049\/jimmunol.181.10.6720","article-title":"TLR ligands in the local treatment of established intracerebral murine gliomas","volume":"181","author":"Grauer","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.wneu.2016.10.015_bib19","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1158\/0008-5472.CAN-14-1151","article-title":"TLR9 is critical for glioma stem cell maintenance and targeting","volume":"74","author":"Herrmann","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.wneu.2016.10.015_bib20","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.cellsig.2011.06.024","article-title":"IGF-1 induced HIF-1\u03b1-TLR9 cross talk regulates inflammatory responses in glioma","volume":"23","author":"Sinha","year":"2011","journal-title":"Cell Signal"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875016310026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875016310026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T13:09:25Z","timestamp":1568466565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875016310026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":20,"alternative-id":["S1878875016310026"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2016.10.015","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor Location and Survival Outcomes in Adult Patients with Supratentorial Glioblastoma by Levels of Toll-Like Receptor 9 Expression","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2016.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}